CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +40,565 | 209,331 | ||
| 2025-06-26 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +40,565 | 168,766 | ||
| 2024-12-12 | TANNENBAUM RENEE P Director | Purchase | +10,000 | $3.42 | $34K | 20,000 |
| 2024-06-27 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +29,700 | 128,201 | ||
| 2023-06-15 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +27,700 | 98,501 | ||
| 2022-09-15 | TANNENBAUM RENEE P Director | Purchase | +6,400 | $1.72 | $11K | 6,400 |
| 2022-09-15 | TANNENBAUM RENEE P Director | Purchase | +3,600 | $1.72 | $6K | 10,000 |
| 2022-03-09 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +26,800 | 70,801 | ||
| 2021-06-10 | TANNENBAUM RENEE P Director | Grant or award · Stock Options | +44,001 | 44,001 |
Page 1 of 1 · 9 trades